Takeda Pharmaceutical Company Limited
TREATMENT OF CNS CONDITIONS
Last updated:
Abstract:
Aspects of the present invention relate to a method of treating an epileptic encephalopathy in a mammal in need thereof, comprising administering a composition comprising an effective amount of (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl)methanone or a pharmaceutically acceptable salt thereof to the mammal.
Status:
Application
Type:
Utility
Filling date:
16 Feb 2022
Issue date:
2 Jun 2022